Toyoda M - Search Results

1

Treatment of parvovirus B-19 (PV B-19) infection allows for successful kidney transplantation without disease recurrence.

Barsoum NR, Bunnapradist S, Mougdil A, Toyoda M, Vo A, Jordan SC. Barsoum NR, et al. Among authors: toyoda m. Am J Transplant. 2002 May;2(5):425-8. doi: 10.1034/j.1600-6143.2002.20505.x. Am J Transplant. 2002. PMID: 12123207 Free article.

2

Treatment of active cytomegalovirus disease with oral ganciclovir in renal allograft recipients: monitoring efficacy with quantitative cytomegalovirus polymerase chain reaction.

Jordan SC, Vo A, Bunnapradist S, Toyoda M, Kamil E. Jordan SC, et al. Among authors: toyoda m. Am J Transplant. 2002 Aug;2(7):671-3. doi: 10.1034/j.1600-6143.2002.20714.x. Am J Transplant. 2002. PMID: 12201370 Free article.

3

Posttransplantation lymphoproliferative disorder presenting as a unilateral leg mass 10 years after kidney transplantation.

Bunnapradist S, Vo A, Toyoda M, Alsabeh R, Lockhart C, Puliyanda D, Jordan SC. Bunnapradist S, et al. Among authors: toyoda m. Transplantation. 2002 Dec 15;74(11):1648-51. doi: 10.1097/00007890-200212150-00029. Transplantation. 2002. PMID: 12490805

4

Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial.

Jordan SC, Tyan D, Stablein D, McIntosh M, Rose S, Vo A, Toyoda M, Davis C, Shapiro R, Adey D, Milliner D, Graff R, Steiner R, Ciancio G, Sahney S, Light J. Jordan SC, et al. Among authors: toyoda m. J Am Soc Nephrol. 2004 Dec;15(12):3256-62. doi: 10.1097/01.ASN.0000145878.92906.9F. J Am Soc Nephrol. 2004. PMID: 15579530 Clinical Trial.

5

Cellular immune responses to cytomegalovirus in renal transplant recipients.

Radha R, Jordan S, Puliyanda D, Bunnapradist S, Petrosyan A, Amet N, Toyoda M. Radha R, et al. Among authors: toyoda m. Am J Transplant. 2005 Jan;5(1):110-7. doi: 10.1111/j.1600-6143.2003.00647.x. Am J Transplant. 2005. PMID: 15636618 Free article.

6

Post-transplant therapy with high-dose intravenous gammaglobulin: Applications to treatment of antibody-mediated rejection.

Jordan SC, Vo AA, Toyoda M, Tyan D, Nast CC. Jordan SC, et al. Among authors: toyoda m. Pediatr Transplant. 2005 Apr;9(2):155-61. doi: 10.1111/j.1399-3046.2005.00256.x. Pediatr Transplant. 2005. PMID: 15787786 Review.

7

Current approaches to treatment of antibody-mediated rejection.

Jordan SC, Vo AA, Tyan D, Nast CC, Toyoda M. Jordan SC, et al. Among authors: toyoda m. Pediatr Transplant. 2005 Jun;9(3):408-15. doi: 10.1111/j.1399-3046.2005.00363.x. Pediatr Transplant. 2005. PMID: 15910400 Review.

8

Co-infection of polyomavirus-BK and cytomegalovirus in renal transplant recipients.

Toyoda M, Puliyanda DP, Amet N, Baden L, Cam V, Radha R, Pao A, Vo A, Bunnapradist S, Moudgil A, Jordan SC. Toyoda M, et al. Transplantation. 2005 Jul 27;80(2):198-205. doi: 10.1097/01.tp.0000165110.78397.93. Transplantation. 2005. PMID: 16041264

9

Intravenous immunoglobulin a natural regulator of immunity and inflammation.

Jordan SC, Toyoda M, Vo AA. Jordan SC, et al. Among authors: toyoda m. Transplantation. 2009 Jul 15;88(1):1-6. doi: 10.1097/TP.0b013e3181a9e89a. Transplantation. 2009. PMID: 19584672 Review.

10

Use of intravenous immune globulin and rituximab for desensitization of highly HLA-sensitized patients awaiting kidney transplantation.

Vo AA, Peng A, Toyoda M, Kahwaji J, Cao K, Lai CH, Reinsmoen NL, Villicana R, Jordan SC. Vo AA, et al. Among authors: toyoda m. Transplantation. 2010 May 15;89(9):1095-102. doi: 10.1097/TP.0b013e3181d21e7f. Transplantation. 2010. PMID: 20110854

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,051 results

Search Page

Filters